PDA Miniverse: Medical Devices, Combination Products and Connected Health Conference 2025 - Recap

Welcome to PDA Miniverse: Medical Devices, Combination Products and Connected Health Conference 2025

We caught up with co-chair Maggie Bandel, MBA, Global Head, Lifecycle Management MSAT at Johnson & Johnson for a behind-the-scenes preview of how the Miniverse fills a gap in the pharma conference space. As a side note, she is especially qualified in her professional work helping shape the future of the industry. She says her focus is on “Driving key peer-to-peer learnings across the industry and leveraging best practices from one segment to another! Some of the best advances in a field are from innovating from outside of that field.”

She reports, “The Miniverse has been years in the making. With the rise of combination products in pharma, we saw a fundamental shift in the content and topics the industry was looking for. The larger PDA Universe event is one of the most well-attended events, and we wanted to be able to host a smaller event in advance of the Universe for those who can't attend the larger event in Vienna.” She adds, attendees will be in good company, “The Miniverse has a unique blend of large pharmaceutical professionals, leading industry experts, and service providers with rich insights and case studies that can be shared.

Developing a relevant and actionable agenda is a challenge and an opportunity. Maggie explains, “We will bring keen insights on trends based on what people are asking for help with. It’s a fusion of hot topics and critical updates on the basics. Attendees can expect deep insights into common challenges across the industry. In other words, you are not alone in your problems, and we are here to help you -- and learn from you! Networking will be a key attraction for attendees as they can talk to peers in the industry about common pitfalls, and challenges, and share lessons learned.” The Miniverse is designed for the peers who will be attending the highly focused program. Maggie describes a great pharma event as one that is centered on the attendees. She says, “We have gathered a terrific panel of presenters and industry leaders to put together a wonderful event, but your participation and insights as an attendee are even more valuable.”

Understandably Maggie is most looking forward to launching an event that has been over five years in the making. If you are sitting on the fence about attending, she says, “This is a great opportunity for those based in the US who cannot travel to the EU Universe event. We specifically created this conference to allow parity across countries for this segment of the industry. Leading industry experts (cross-function) will be leading the discussions and provide their perspectives on challenges and easy wins. You won't find this type of event elsewhere!”